Announce Date | 04/22/2025 |
EPS Normalized Actual | $0.6 In Line |
EPS GAAP Actual | $0.6 In Line |
Revenue Actual | $5.417B |
Revenue Surprise | Beat by $5417M |
Announce Date | 12/31/1969 (Pre-Market) |
EPS Normalized Estimate | $ |
EPS GAAP Estimate | $ |
Revenue Estimate | $0B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2029 | 3.66 | 5.8 | 3.42535 | 3.84508 | 1 |
Dec 2028 | 4.74 | 4.47 | 4.48466 | 4.91151 | 4 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | 0.24 | 0.24 | 5.417B | -7.14% | 5417M |
FQ4 2024 (Dec 2024) | 0.7 | 0.7 | 5.61B | -2.3% | 5610M |
FQ3 2024 (Sep 2024) | 0.65 | 0.65 | 5.697B | -1.88% | 5697M |
FQ2 2024 (Jun 2024) | 0.8 | 0.8 | 5.833B | 0.6% | 5833M |
FQ1 2024 (Mar 2024) | 0.68 | 0.68 | 5.804B | 2.19% | 5804M |
FQ4 2023 (Dec 2023) | 0.74 | 0.74 | 5.739B | 2.74% | 5739M |
FQ3 2023 (Sep 2023) | 0.8 | 0.8 | 5.804B | 7.7% | 5804M |
FQ2 2023 (Jun 2023) | 1.05 | 1.05 | 5.798B | 12.49% | 5798M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2029 (Sep 2029) | 0 | -- | 0 | 0 | 8 |
FQ2 2029 (Jun 2029) | 0 | -- | 0 | 0 | 7 |
FQ1 2029 (Mar 2029) | 0 | -- | 0 | 0 | 6 |
FQ4 2028 (Oct 2028) | 0 | -- | 0 | 0 | 15 |
FQ3 2028 (Jul 2028) | 0 | -- | 0 | 0 | 8 |
FQ2 2028 (Jun 2028) | 0 | -- | 0 | 0 | 8 |
FQ1 2028 (Mar 2028) | 0 | -- | 0 | 0 | 9 |
FQ4 2027 (Oct 2027) | 0 | -- | 0 | 0 | 10 |
FQ3 2027 (Jul 2027) | 0 | -- | 0 | 0 | 7 |
FQ2 2027 (Jun 2027) | 0 | -- | 0 | 0 | 15 |
FQ1 2027 (Mar 2027) | 0 | -- | 0 | 0 | 7 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2029 (Sep 2029) | 6.59B | -- | 6.37B | 6.7B | 9 |
FQ2 2029 (Jun 2029) | 6.48B | -- | 6.28B | 6.6B | 9 |
FQ1 2029 (Mar 2029) | 6.32B | -- | 6.11B | 6.42B | 9 |
FQ4 2028 (Oct 2028) | 6.9B | -- | 6.9B | 6.9B | 11 |
FQ3 2028 (Jul 2028) | 6.76B | -- | 6.76B | 6.76B | 6 |
FQ2 2028 (Jun 2028) | 6.76B | -- | 6.76B | 6.76B | 6 |
FQ1 2028 (Mar 2028) | 6.61B | -- | 6.61B | 6.61B | 12 |
FQ4 2027 (Oct 2027) | 6.69B | -- | 6.69B | 6.69B | 8 |
FQ3 2027 (Jul 2027) | 6.56B | -- | 6.56B | 6.56B | 7 |
FQ2 2027 (Jun 2027) | 6.56B | -- | 6.56B | 6.56B | 7 |
FQ1 2027 (Mar 2027) | 6.35B | -- | 6.35B | 6.35B | 10 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | 0.24 | 0.24 | 100% | |
FQ4 2024 (Dec 2024) | 0.7 | 0.7 | 100% | |
FQ3 2024 (Sep 2024) | 0.65 | 0.65 | 100% | |
FQ2 2024 (Jun 2024) | 0.8 | 0.8 | 100% | |
FQ1 2024 (Mar 2024) | 0.68 | 0.68 | 100% | |
FQ4 2023 (Dec 2023) | 0.74 | 0.74 | 100% | |
FQ3 2023 (Sep 2023) | 0.8 | 0.8 | 100% | |
FQ2 2023 (Jun 2023) | 1.05 | 1.05 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $0B | $5.42B | $5417M | 100% |
FQ4 2024 (Dec 2024) | $0B | $5.61B | $5610M | 100% |
FQ3 2024 (Sep 2024) | $0B | $5.7B | $5697M | 100% |
FQ2 2024 (Jun 2024) | $0B | $5.83B | $5833M | 100% |
FQ1 2024 (Mar 2024) | $0B | $5.8B | $5804M | 100% |
FQ4 2023 (Dec 2023) | $0B | $5.74B | $5739M | 100% |
FQ3 2023 (Sep 2023) | $0B | $5.8B | $5804M | 100% |
FQ2 2023 (Jun 2023) | $0B | $5.8B | $5798M | 100% |